NASDAQ:GRCE | Cash Flow Statement | Grace Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$15.79M-$3.22M$0.00
2026-03-31-$1.18M-$1.7M$0.00$0.00
2025-12-31-$2.32M
2025-09-30-$938,000.00
2025-06-30-$3.36M-$1.8M$0.00-$327,000.00
2025-03-31$636,000.00-$2.95M$0.00$14.03M
2024-12-31-$4.16M
2024-09-30-$3.43M
2024-06-30-$2.62M-$3.6M-$15,000.00$0.00
2024-03-31-$3.17M-$2.09M$6.55M$0.00
2023-12-31-$2.39M
2023-09-30-$3.27M
2023-06-30-$4.02M-$6.24M$0.00$0.00
2023-03-31-$29.09M-$3.33M$4.99M$0.00
2022-12-31-$3.89M
2022-09-30-$4.93M
2022-06-30-$4.52M-$5.43M$13.26M$195,000.00
2022-03-31-$3.9M-$3.15M$11,000.00$0.00
2021-12-31-$3.78M-$4.58M$557,000.00$0.00
2021-09-30$981,000.00-$6.1M$2.84M$0.00
2021-06-30-$3.12M-$3.4M-$6.93M$0.00
2021-03-31-$5.65M-$1.76M-$8.42M$34.68M
2020-12-31-$3.22M-$4.21M-$1.37M$19.75M
2020-09-30-$6.15M-$4.18M-$33,000.00$3.43M
2020-06-30-$4.67M-$4.17M$36,000.00-$36,000.00$1.64M
2020-03-31$16.62M-$2.9M-$399,000.00-$530,000.00
2019-12-31-$12.12M-$7.1M-$347,000.00$7.12M
2019-09-30-$21.16M-$6.15M$3.37M$6.6M
2019-06-30-$8.85M-$6.82M$19,000.00$5.52M$34,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$7.79M-$8.87M$0.00$3.71M
2025-03-31-$9.57M-$14.9M$0.00$14.03M
2024-03-31-$12.85M-$12.33M$104,000.00$7.36M
2023-03-31-$42.43M-$15.91M$13.15M$304,000.00
2022-03-31-$9.82M-$17.23M-$3.52M$0.00
2021-03-31-$19.68M-$14.32M-$9.86M$59.49M
2020-03-31-$25.51M-$22.95M$8.14M$13.18M
2019-03-31-$39.37M